Akero Therapeutics, Inc. (AKRO) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Dilution Analysis

Medium Risk

Moderate dilution risk

Last updated: November 07, 2025

Risk Assessment Details

Potential Dilution: 0.0% of current shares

Recent Dilution: 19.33% (2 years)

Historical Dilution Factor: moderate recent dilution

Outstanding Shares

82M

Potential Supply

Additional shares possible

Splits

None

Past 2 years

Summary

AKRO currently has 82M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 19.33% over the past 2 years through share issuances.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding	Supply
Nov 07, 2025	10-Q filing \| 82.0M shares outstanding	82M	0
May 12, 2025	10-Q filing \| 78.7M shares outstanding	79M	0
Feb 28, 2025	10-K filing \| 79.6M shares outstanding	80M	0
Nov 08, 2024	10-Q filing \| 69.4M shares outstanding	69M	0
Aug 09, 2024	10-Q filing \| 69.2M shares outstanding	69M	0
May 10, 2024	10-Q filing \| 69.2M shares outstanding	69M	0
Feb 29, 2024	10-K filing \| 52.6M shares outstanding	53M	0
Nov 13, 2023	10-Q filing \| 55.6M shares outstanding	56M	0
Aug 11, 2023	10-Q filing \| 51.9M shares outstanding	52M	0
May 15, 2023	10-Q filing \| 46.9M shares outstanding	47M	300K
Mar 17, 2023	10-K filing \| 47.0M shares outstanding	47M	270K
Nov 04, 2022	10-Q filing \| 46.8M shares outstanding	47M	480K
Aug 05, 2022	10-Q filing \| 35.4M shares outstanding	35M	12M
May 06, 2022	10-Q filing \| 35.0M shares outstanding	35M	12M
Feb 25, 2022	10-K filing \| 34.8M shares outstanding	35M	12M
Nov 12, 2021	10-Q filing \| 34.9M shares outstanding	35M	12M
Aug 13, 2021	10-Q filing \| 34.8M shares outstanding	35M	12M
May 13, 2021	10-Q filing \| 34.8M shares outstanding	35M	12M
Mar 16, 2021	10-K filing \| 34.8M shares outstanding	35M	12M
Nov 12, 2020	10-Q filing \| 34.7M shares outstanding	35M	13M
Aug 12, 2020	10-Q filing \| 34.7M shares outstanding	35M	13M
Jul 06, 2020	S-1 filing: Akero Therapeutics, Inc. is offering 4,750,000 shares of its common stock.	29M	19M
Jul 01, 2020	S-3 filing: Akero Therapeutics, Inc. intends to offer up to $300,000,000 in aggregate principal amount of common stock, preferred stock, debt securities, warrants and/or units, in any combination.	29M	13M
May 13, 2020	10-Q filing \| 28.7M shares outstanding	29M	0
Mar 16, 2020	10-K filing \| 28.6M shares outstanding	29M	0

Back to AKRO Details